Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003130090> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2003130090 endingPage "1007" @default.
- W2003130090 startingPage "1002" @default.
- W2003130090 abstract "The long term effectiveness and tolerance of terguride, a new ergot derivative, as initial therapy were evaluated in 20 patients with pathological hyperprolactinemia (PHP; group A) and 7 patients with acromegaly. We also studied 10 patients with PHP whose treatment was changed from bromocryptine or lisuride to terguride (group B). Terguride, given for at least 6 months in divided doses ranging from 0.25-1.50 mg/ day to group A patients, resulted in normal (11 patients) or markedly reduced plasma PRL levels. Gonadal function was restored in all but 2 patients in this group, and the tumors shrank in 3 of 5 patients with a macroprolactinoma and in 1 of 3 patients with a microprolactinoma. In group B patients, positive effects of the previous treatment on PRL levels, gonadal function, and tumor growth were maintained by terguride. Terguride suppressed plasma GH levels below 50% of baseline in 4 of the 7 acromegalic patients. Two of the 27 patients initially treated with terguride complained of mild nausea and postural hypotension only after the first dose (0.25 mg) of the drug. No patient in group B had any side-effects during terguride, with the exception of 1 patient who was also intolerant to bromocryptine. We conclude that terguride is an effective well tolerated dopaminergic agent in PHP. (J Clin Endocrinol Metab63:1002" @default.
- W2003130090 created "2016-06-24" @default.
- W2003130090 creator A5020380979 @default.
- W2003130090 creator A5026746662 @default.
- W2003130090 creator A5051104435 @default.
- W2003130090 creator A5053390459 @default.
- W2003130090 creator A5062034246 @default.
- W2003130090 creator A5065573499 @default.
- W2003130090 creator A5075614878 @default.
- W2003130090 creator A5088492491 @default.
- W2003130090 creator A5089562818 @default.
- W2003130090 date "1986-10-01" @default.
- W2003130090 modified "2023-10-14" @default.
- W2003130090 title "Chronic Treatment of Pathological Hyperprolactinemia and Acromegaly with the New Ergot Derivative Terguride*" @default.
- W2003130090 cites W2005963838 @default.
- W2003130090 cites W2007794565 @default.
- W2003130090 cites W2010563165 @default.
- W2003130090 cites W2073012728 @default.
- W2003130090 cites W2074864966 @default.
- W2003130090 cites W2130098839 @default.
- W2003130090 doi "https://doi.org/10.1210/jcem-63-4-1002" @default.
- W2003130090 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3745401" @default.
- W2003130090 hasPublicationYear "1986" @default.
- W2003130090 type Work @default.
- W2003130090 sameAs 2003130090 @default.
- W2003130090 citedByCount "36" @default.
- W2003130090 countsByYear W20031300902015 @default.
- W2003130090 countsByYear W20031300902019 @default.
- W2003130090 countsByYear W20031300902022 @default.
- W2003130090 crossrefType "journal-article" @default.
- W2003130090 hasAuthorship W2003130090A5020380979 @default.
- W2003130090 hasAuthorship W2003130090A5026746662 @default.
- W2003130090 hasAuthorship W2003130090A5051104435 @default.
- W2003130090 hasAuthorship W2003130090A5053390459 @default.
- W2003130090 hasAuthorship W2003130090A5062034246 @default.
- W2003130090 hasAuthorship W2003130090A5065573499 @default.
- W2003130090 hasAuthorship W2003130090A5075614878 @default.
- W2003130090 hasAuthorship W2003130090A5088492491 @default.
- W2003130090 hasAuthorship W2003130090A5089562818 @default.
- W2003130090 hasConcept C126322002 @default.
- W2003130090 hasConcept C134018914 @default.
- W2003130090 hasConcept C2776856834 @default.
- W2003130090 hasConcept C2777095659 @default.
- W2003130090 hasConcept C2777433750 @default.
- W2003130090 hasConcept C2779064019 @default.
- W2003130090 hasConcept C2780580376 @default.
- W2003130090 hasConcept C2984496839 @default.
- W2003130090 hasConcept C71315377 @default.
- W2003130090 hasConcept C71924100 @default.
- W2003130090 hasConceptScore W2003130090C126322002 @default.
- W2003130090 hasConceptScore W2003130090C134018914 @default.
- W2003130090 hasConceptScore W2003130090C2776856834 @default.
- W2003130090 hasConceptScore W2003130090C2777095659 @default.
- W2003130090 hasConceptScore W2003130090C2777433750 @default.
- W2003130090 hasConceptScore W2003130090C2779064019 @default.
- W2003130090 hasConceptScore W2003130090C2780580376 @default.
- W2003130090 hasConceptScore W2003130090C2984496839 @default.
- W2003130090 hasConceptScore W2003130090C71315377 @default.
- W2003130090 hasConceptScore W2003130090C71924100 @default.
- W2003130090 hasIssue "4" @default.
- W2003130090 hasLocation W20031300901 @default.
- W2003130090 hasLocation W20031300902 @default.
- W2003130090 hasOpenAccess W2003130090 @default.
- W2003130090 hasPrimaryLocation W20031300901 @default.
- W2003130090 hasRelatedWork W1968902787 @default.
- W2003130090 hasRelatedWork W1988691717 @default.
- W2003130090 hasRelatedWork W2048200311 @default.
- W2003130090 hasRelatedWork W2062193095 @default.
- W2003130090 hasRelatedWork W2084646198 @default.
- W2003130090 hasRelatedWork W2089315288 @default.
- W2003130090 hasRelatedWork W2416158939 @default.
- W2003130090 hasRelatedWork W2422841958 @default.
- W2003130090 hasRelatedWork W60472106 @default.
- W2003130090 hasRelatedWork W77485291 @default.
- W2003130090 hasVolume "63" @default.
- W2003130090 isParatext "false" @default.
- W2003130090 isRetracted "false" @default.
- W2003130090 magId "2003130090" @default.
- W2003130090 workType "article" @default.